Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges

Journal of Clinical Neuroscience

Volumn 22, Issue 10, 2015, Pages 1562-1567

  Wong, Anni ^a,b   Eloy, Jean Anderson ^a,b,c   Couldwell, William T ^d   Liu, James K ^a,b,c  

^a NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

^b New Jersey Medical School   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical manifestations; Dopamine agonist therapy; Endoscopic transsphenoidal surgery; Hyperprolactinemia; Pituitary adenoma; Prolactin; Prolactinoma

Indexed keywords

PROLACTIN; DOPAMINE RECEPTOR STIMULATING AGENT;

ARTICLE; CAUSAL ATTRIBUTION; CLINICAL FEATURE; DIAGNOSTIC TEST; HUMAN; HYPERPROLACTINEMIA; PHYSICAL EXAMINATION; PREGNANCY TEST; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SYMPTOM ASSESSMENT; THYROID FUNCTION TEST; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROCEDURES; SPHENOID SINUS;

DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; HUMANS; HYPERPROLACTINEMIA; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; SPHENOID SINUS;

EID: 84941171126     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2015.03.058     Document Type: Review

References (29)

1. M. Kars, O.M. Dekkers, A.M. Pereira, and et al. Update in prolactinomas Neth J Med 68 2010 104 112
2. J.A. Schlechte Clinical practice. Prolactinoma N Engl J Med 349 2003 2035 2041
3. D. Maiter, and E. Delgrange Therapy of endocrine disease: the challenges in managing giant prolactinomas Eur J Endocrinol 170 2014 R213-27
4. K.R. Cho, K.I. Jo, and H.J. Shin Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience Brain Tumor Res Treat 1 2013 71 77
5. J.K. Liu, and W.T. Couldwell Contemporary management of prolactinomas Neurosurg Focus 16 2004 E2
6. M.C. Oh, S. Kunwar, L. Blevins, and et al. Medical versus surgical management of prolactinomas Neurosurg Clin N Am 23 2012 669 678
7. F.F. Casanueva, M.E. Molitch, J.A. Schlechte, and et al. Guidelines of the pituitary society for the diagnosis and management of prolactinomas Clin Endocrinol 65 2006 265 273
8. J.K. Liu, M.D. Krieger, A. Amar, W.T. Couldwell, and M.H. Weiss Prolactinomas A. Quinones-Hinojosa, Schmidek & Sweet Operative Neurosurgical Techniques: Indications, Methods, and Results 2 ed. 2012 Saunders Elsevier Philadelphia
9. M.E. Molitch Prolactinoma in pregnancy Best Pract Res Clin Endocrinol Metab 25 2011 885 896
10. W.A. Mann Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach Eur J Clin Invest 41 2011 334 342
11. I. Halperin Rabinovich, R. Camara Gomez, M. Garcia Mouriz, and et al. [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia] Endocrinol Nutr 60 2013 308 319
12. A. Klibanski Clinical practice. Prolactinomas N Engl J Med 362 2010 1219 1226
13. P. Iglesias, and J.J. Diez Macroprolactinoma: a diagnostic and therapeutic update QJM 106 2013 495 504
14. H. Nishioka, J. Haraoka, and K. Akada Growth potential of prolactinomas in men: is it really different from women? Surg Neurol 59 2003 386 390 [discussion 390-1]
15. J.A. Schlechte Long-term management of prolactinomas J Clin Endocrinol Metab 92 2007 2861 2865
16. L. Vilar, M. Fleseriu, and M.D. Bronstein Challenges and pitfalls in the diagnosis of hyperprolactinemia Arq Bras Endocrinol Metabol 58 2014 9 22
17. S. Melmed, F.F. Casanueva, A.R. Hoffman, and et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 96 2011 273 288
18. V.K. Prabhakar, and J.R. Davis Hyperprolactinaemia Best Pract Res Clin Obstet Gynaecol 22 2008 341 353
19. F.C. Albuquerque, M.H. Weiss, K. Kovacs, and et al. A functioning composite 'corticotroph' pituitary adenoma with interspersed adrenocortical cells Pituitary 1 1999 279 284
20. L. Vilar, M.C. Freitas, L.A. Naves, and et al. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients J Endocrinol Invest 31 2008 436 444
21. R. John, I.F. McDowell, M.F. Scanlon, and et al. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers Clin Chem 46 2000 884 885
22. J.A. Schlechte The macroprolactin problem J Clin Endocrinol Metab 87 2002 5408 5409
23. M.N. Fahie-Wilson, and S.G. Soule Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol Ann Clin Biochem 34 1997 252 258
24. M. do Carmo Dias Gontijo, L. de Souza Vasconcellos, and A. Ribeiro-Oliveira Jr. Hook effect and linear range in prolactin assays: distinct confounding entities Pituitary 2015 [Epub ahead of print]
25. M. Fleseriu, M. Lee, M.M. Pineyro, and et al. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect' J Neurooncol 79 2006 41 43
26. A.L. Barkan, and W.F. Chandler Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report Neurosurgery 42 1998 913 915 [discussion 915-6]
27. E. Delgrange, R. de Hertogh, L. Vankrieken, and et al. Potential hook effect in prolactin assay in patients with giant prolactinoma Clin Endocrinol 45 1996 506 507
28. E. St-Jean, F. Blain, and R. Comtois High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas Clin Endocrinol (Oxf) 44 1996 305 309
29. R. Comtois, F. Robert, and J. Hardy Immunoradiometric assays may miss high prolactin levels Ann Intern Med 119 1993 173